Skip to content

Investment Purchases at other companies

Viking Therapeutics logo
Viking TherapeuticsVKTX
$72.44M-68.9%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$153.79M-54.7%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$554.43M+41.7%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$148.18M-15.3%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$42.2M+25.9%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$170.2M+281%

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$43.8M-15.8%
Net income-$41.3M-15.0%
EPS (diluted)-$0.37+11.9%

Balance sheet

See full
Cash & equivalents$229.1M+283%
Total debt$5.6M+307%
Total equity$273.2M+35.6%
Total assets$293.6M+33.7%

Cash flow

See full
Operating cash flow-$36.9M+7.4%
CapEx$86.0K+330%
Free cash flow-$28.0M+52.6%

Valuation

See full
Market cap$1.82B+390%
Enterprise value$1.6B+414%

Profitability

See full
Gross margin100%+6.9pp
Operating margin-47,349.8%-47,409pp
Net margin-45,096.2%-45,152pp
FCF margin-39,826.7%-39,847pp

Returns & leverage

See full
Return on equity-63.3%-12.2pp
Debt / equity0.0×
Current ratio17.9×+5.8×

Where this comes from

Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amylyx Pharmaceuticals, Inc.'s investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amylyx Pharmaceuticals, Inc.'s investment purchases?
Amylyx Pharmaceuticals, Inc. (AMLX) reported investment purchases of $19.74M in Q1 2026.
How has Amylyx Pharmaceuticals, Inc.'s investment purchases changed year-over-year?
Amylyx Pharmaceuticals, Inc.'s investment purchases decreased by 81.0% year-over-year, from $103.65M to $19.74M.
What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s investment purchases?
Over 3 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s investment purchases has grown at a 67.8% compound annual growth rate (CAGR), from $49.05M to $231.82M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.